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A bstract> The leukocyte function-associated 
molecule-1 (LFA-1) plays a key role in cell adhesion 
processes between cells of the immune system. We in­
vestigated the mechanism that may regulate LFA- 
1-ligand interactions, which result in cell-cell adhe­
sion. To this end we employed an intriguing anti-LFA-l 
a mAh (NKI-L16), capable of inducing rather than 
inhibiting cell adhesion. Aggregation induced by NKI- 
L16 or Fab fragments thereof is not the result of sig­
nals transmitted through LFA-1. The antibody was 
found to recognize a unique Ca2+-dependent activation 
epitope of LFA-1, which is essentially absent on rest­
ing lymphocytes, but becomes induced upon in vitro
dicating that expression of the NKI-L16 epitope is es­
sential for LFA-1 to mediate adhesion. However, ex­
pression of the NKI-L16 epitope in itself is not 
sufficient for cell binding since cloned T lymphocytes 
express the NKI-L16 epitope constitutively at high lev­
els, but do not aggregate spontaneously. Based on 
these observations we propose the existence of three 
distinct forms of LFA-1: (a) an inactive form, which 
does not, or only partially exposes the NKI-L16 epi­
tope, found on resting cells; (,b) an intermediate, NKI- 
L16+ form, expressed by mature or previously acti­
vated cells; and (c) an active (NKI-L16+) form of LFA-1, 
capable of high affinity ligand binding, obtained af-
culture. Expression of this epitope correlates well with ter specific triggering of a lymphocyte through the
the capacity of cells to rapidly aggregate upon stimu­
lation by PMA or through the TCR/CD3 complex, in-
TCR/CD3 complex, by PMA, or by binding of NKI- 
L16 antibodies.
T h e  lymphocyte function-associated antigen-1 (LFA- 
l)1 is a member of the leukocyte cellular adhesion mol­
ecule (LeuCAM) group, which belongs to the integrin 
family of adhesion receptors (Hynes, 1987). The LeuCAM 
group consists of three structurally related heterodimeric 
molecules: LFA-1, CR3 (Mo-1), and pl50,95 (Sanchez-Ma- 
drid et al., 1983). These molecules share a common beta 
subunit with a molecular mass of 95 kD (CD18), but differ 
in their alpha subunits with a molecular mass of 170, 165, 
and 150 kD (for CD1 la, b, and c), respectively (Keizer et al.,
1985).
LFA-1 is expressed on the cell surface of most leukocytes 
and plays an important immunoregulatory role by mediating 
adhesion among leukocytes or between leukocytes and other 
cell types (Springer et al., 1982, 1987; Martz, 1987). The
Gerrit D. Keizer’s present address is Holland Biotechnology, Leiden, The 
Netherlands.
1. Abbreviations used in this paper: AIM, activation inducer molecule; 
CTL, cytotoxic T lymphocyte; ICAM, intercellular adhesion molecule; 
LFA-1, lymphocyte function-associated antigen-1; PDBU, phorbol-12,13 
dibutyrate; PKC, protein kinase C.
function of LFA-1 as an intercellular adhesion molecule has 
been defined by the ability of anti-LFA-l mAbs to inhibit 
adhesion-dependent leukocyte functions, such as cytotoxic T 
lymphocyte (CTL)-target cell interaction (Sanchez-Madrid 
et al., 1982; Spits et al., 1986) and many other homotypic 
and heterotypic cell-cell interactions (Haskard et al., 1986; 
MentzeretaL, 1986; Rothlein and Springer, 1986). Cell ad­
hesion mediated by LFA-1 is established by binding of LFA-1 
to its ligands on the opposing cell, Recently two ligands were 
defined, intercellular adhesion molecule (ICAM)-l and -2 
(Marlin and Springer, 1987; Staunton et al., 1989). LFA-1- 
mediated binding is energy and temperature dependent and 
requires an intact cytoskeleton (Rothlein and Springer,
1986). Furthermore, LFA-1-mediated cell-cell interactions 
strictly depend on the presence of Mg2+ ions, and at subop- 
timal concentrations also require Ca2+ ions (Rothlein and 
Springer, 1986; Martz, 1980; Dustin and Springer, 1989). 
Ca2+ and Mg2+ may contribute to the stabilization of the 
LFA-1 a,|3 subunit interaction. Structural studies of the LFA-1 
ol chain have revealed three cation binding repeats in prox­
imity of the I (“inserted/interactive”) domain (Larson et al., 
1988). Expression of a Mg2+-dependent epitope located on
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the leukocyte integrin a  subunits, possibly associated with 
functionally active molecules (Dransfield and Hogg, 1989), 
further illustrates the importance of cations in regulation of 
leukocyte adhesion.
The precise mechanism by which LFA-l promotes inter­
cellular adhesion has not yet been elucidated. Stimuli that 
lead to activation of PKC, such as antigen, lectins, or phor- 
bol esters have been shown to induce LFA-l-depen dent 
aggregation of B and T lymphocytes (Rothlein and Springer, 
1986; Patarroyo et al., 1985, 1986), Recently, antibodies 
directed to other cell surface molecules, such as CD2, CD3, 
or CD43, and antibodies directed against LFA-l itself, were 
found to induce LFA-l-dependent aggregation and adhesion 
(Axelsson et al., 1988; Keizer et al., 1988; Dustin and 
Springer, 1989; Van Kooyk et ah, 1989), These observations 
suggest that activation of LFA-l may be required for stable 
cell adhesion.
In this study we investigated the mode of action of LFA-l 
employing a unique mAb, directed against the a  chain of 
LFA-l, that is capable of inducing LFA-l-depen dent cell 
adhesion (Keizer et al., 1988). The results demonstrate that 
this antibody recognizes a Ca2+-dependent epitope on LFA-l 
that is generated upon cell activation. Binding of the anti­
body stimulates lymphocyte adhesion, possibly by intramo­
lecular changes in LFA-l.
Materials and Methods
Cell Lines and Cell Culture
The human cytolytic, alloreactive T cell clone JS-136 (CD3+CD4H~CD16~) 
used in this study is directed against a HLA-DRw6 determinant (Borst et 
al., 1986). Cloned T cells were cultured in Is cove’s medium supplemented 
with 5 % human serum and stimulated weekly with irradiated allogeneic pe­
ripheral blood mononuclear cells (PBMC) and cells of the EBV transformed 
B cell line JY, phytohaemagglutinin (PHA, 0.2 jug/ml) and IL-2 (50 U/ml) 
(Proleukin, batch LAP-704) kindly provided by Cetus Corporation (Emery­
ville, CA). JY cells were maintained in Iscove’s medium containing 10% 
FCS. A homogenous population of highly purified T lymphocytes were iso­
lated from buffy coats of healthy donors by centrifugal elutriation, as de­
scribed previously (Figdor et aL} 1981), and were cultured in Iscove’s me­
dium containing 10% FCS.
Antibodies
The mAbs SPV-L7 (IgGl), NKI-L15 (IgGl), and NKI-L16 (IgG2a) reactive 
with the a chain of human LFA-l (CDlla) and CLB LFA-1/1 (IgGl), reactive 
with the (3 chain of LFA-l (CD18), were raised as described previously 
(Keizer et aL, 1985, 1988; Miedema et al., 1984). mAb RR1/1, directed 
against ICAM-1 (CD54) was kindly provided by Dr. T. Springer (Center for 
Blood Research, Boston, MA) (Marlin and Springer, 1987). Direct FITC- 
conjugated mAb TB30 reactive with the IL-2R a-chain (CD25), was kindly 
provided by Dr. R. van Lier (Central Laboratory of Blood Transfusion Ser­
vice, Amsterdam, The Netherlands). Direct FITC-conjugated anti-AIM 
mAb was kindly provided by Dr. F. Sanchez-Madrid (Hospital de la Prin­
cesa, Madrid, Spain) (Cebrian etal., 1988). mAbs SPV-T3b (IgG2a), reac­
tive with CD3 and anti“CD71 are described previously (Spits et al., 1983; 
Van de Rijn, 1983). mAb CEM (anti-KLH, IgGl) was used as control 
antibody for negative antibody binding. The reaction pattern of a control anti­
body of the IgG2A isotype did not differ from that of the IgGl control 
antibodies (data not shown). Fab fragments of NKI-L16 were generated by 
papain digestion as described by Mather et al. (1987) and checked for purity 
by SDS-PAGE, followed by silver staining.
a
Immunofluorescence
Cells were incubated (30 min, 0°C) in PBS, containing 1% wt/vol BSA 
(Sigma Chemical Co., St. Louis, MO) and 0.01% wt/vol sodium azide, with 
appropriate dilutions of the different mAbs, followed by incubation with
FITC-labeied goat F(ab02 anti-mouse IgG antibody (Nordic, Tilburg, The 
Netherlands) for 30 min at 0°C. The relative fluorescence intensity was 
measured by FACScan analysis (Becton Dickinson & Co., Oxnard, CA). 
To determine the cation-dependent expression of the NKI-L16 epitope on 
lymphocytes, JS-136 T cells were incubated for 1 h at 37°C with 0.9% NaCl 
containing 1% wt/vol BSA and 5 mM EDTA or 5 mM EGTA to remove 
all bound cations. After incubation with EDTA or EGTA the viability of 
the cells was determined by trypan blue exclusion, and was always >95%. 
Subsequently, cells were washed twice in cation-depleted PBS (dPBS) to 
remove the excess of EDTA or EGTA present. Cation-depleted PBS was ob­
tained by rotary mixing PBS with 1% wt/vol Chelex 100 microspheres (Bio­
rad Laboratories, Cambridge, MA) for 4 h at 4°C. Reconstitution of cat­
ions was followed through the addition of 1 mM MgCh or 1 mM CaCl*. 
Cations were incubated for 30 min at 4°C, after which the fluorescence as­
say was performed as described, using mAbs that were also depleted for 
cations, by 4 h incubation with Chelex 100 microspheres.
Qualitative Aggregation Assay
Homotypic aggregation of cells was measured in a qualitative manner by 
a modification of the method described by Rothlein and Springer (1986). 
Cells were resuspended in Iscove’s medium containing 10 % FCS and seeded 
in 96-well microtiter plates (no. 3595; Costar Data Packaging Corp., Cam­
bridge, MA) at 2 x 105 cells per well in 50 ^ 1. mAbs (0.1-10 /tg/ml) or 
PM A (1-10 ng/ml) were added in a volume of 50 /¿I. Cells were incubated 
for various periods (see Results) at 37°C and aggregate formation was deter­
mined by at least two investigators using a light microscope. Scores ranged 
from <1 to 100, where <1 indicated that essentially no cells were aggregated 
in clusters and 10, 20, 40, 60, 80, and 100 corresponded with cell aggrega­
tions of: <10%, <30%, <50%, <70%, >80% in compact clusters, and 
>90% in large compact clusters, respectively. Cell aggregation was induced 
by the addition of NKJ-L16 mAb, anti-CD3 mAb, PMA, or phorbol-12,13 
dibutyrate (PDBU) in concentrations as indicated.
To inhibit cell aggregation, various agents known to inhibit signal trans­
duction were added: Staurosporine (200 nM; Kyowa Hakko, Europe 
GMBH, Düsseldorf, FRG); l-O-alkyl-2-O-methy 1-glycerol (AMG, 60 mM; 
Bachem AG Bubendorf, Switzerland); and sodium azide (0.2% wt/vol),
Cation dependence was determined by preincubation of cells with 5 mM 
EDTA or 5 mM EGTA for 30 min at 4°C, after which the aggregation assay 
was performed at 37°C.
Quantitative Aggregation Assay
Homotypic aggregation was quantitatively determined by double fluores­
cence (Kuijpers et al., 1990). Cells (1 x 106 cells/ml in Iscove’s medium) 
were stained separately with the red dye Hydroethidine (HE; Polyscience, 
Inc., Warrington, PA; 80 mg/ml in N,N-dimethylacetonide) at concentra­
tions of 3 ng/ml, or with the green dye sulfofluorescein diacetate (SFDA; 
Molecular Probes, Junction City, OR) at a concentration of 5 ¿ig/ml. After
1 h of incubation at 37°C, cells were washed twice with Iscove’s medium 
and 10% FCS and seeded in flatbottom plates, 1 X 105 HE-labeled cells 
per well. Subsequently, 1 X 105 SFDA-labeled cells were added. Aggrega­
tion took place at 37 °C, and at different time points cells were fixed with 
0.5 % paraformaldehyde (PFA) in PBS. The fixed samples were measured 
in a FACScan. Double-colored aggregates were calculated as a percentage 
of the total colored events counted. Cell aggregation was induced by the ad­
dition of NKI-L16 mAb, anti-CD3 mAb, PMA in concentrations as indi­
cated. Cell aggregation was inhibited by the addition of anti-LFA-1 mAb 
(LFA-1/1) or anti-ICAM-l mAb (RR1/1).
Binding of JS-136 T Cells to Purified ICAM-1
JS-136 T cells were labeled with 51Cr by incubation of cells at 4 x 106 
cells/ml with 200 /¿Ci/ml Na2MCr04 for 1.5 h at 37°C in complete media. 
Purified ICAM-1, kindly provided by Dr. S. Shaw (National Institutes of 
Health, Bethesda, MD), was obtained by immunoaffinity chromatography 
from a Triton X-100 lysate of cells from the Reed-Sternberg line L428, 
(Marlin et al., 1987; Makgoba et al., 1988). A 1:100 dilution of purified 
ICAM-1 was incubated in microtiter wells (Sterilin) in 50 /¿I PBS overnight 
at 4°C These and control wells were blocked with 100 ¡x\ of 1% BSA in 
PBS for 1 h at 37°C after which they were washed twice with PBS. 
[51Cr]JS-136 cells were preincubated for 30 min at 4°C with or without 
mAb NKI-L16 10 ¿tg/ml in Iscove’s medium and added (50 fi\) to the coated 
wells. The cells were allowed to settle during a 1-h incubation at 4°C, fol­
lowed by an incubation at 37°C for 30 min. Nonadherent cells were removed
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by washing with warm Iscove’s medium. Subsequently» cells were lysed with 
100 f*l of 1% Triton X400 in PBS and radioactivity was quantified. Results 
are expressed as the mean percent of cells binding from three replicate 
wells.
Radiolabeling and Immunoprécipitation
Cells were surface labeled with Na125I (Amersham International, Amer- 
sham, UK) through the lactoperoxidase method (Pink and Ziegler, 1979). 
For immunoprécipitation, peripheral blood mononuclear cells (PBMCs) 
(30 X  106) were lysed for 1 h at 4°C in immunoprécipitation buffer (IPB), 
which contained 1% NP-40, 50 mM Triethanol ami ne (pH 7.4), 150 tnM 
NaCl and as protease inhibitors, 1 mM PMSF, ovomucoid trypsin inhibitor 
(0,02 mg/ml, Sigma Chemical Co.; 0.01 M TEA/150mM NaCl buffer), 0.02 
mg/ml leupeptin, and 1 mM Nd-P-tosyl-L-lysine chloromethyl ketone were 
added. The IPB was depleted for Ca2+ and Mg2+ ions, or Ca2+ ions only, 
by the addition of 5 mM EDTA or 5 mM EGTA, respectively. Immunopré­
cipitation studies in the presence of cations were performed through the ad­
dition of 2 mM CaCl2 and 2 mM MgCk, or by the addition of 2 mM CaCh 
only. Nuclear debris was removed from the lysates by centrifugation at 
13,000 g for 15 min at 4°C. Lysates were precleared by successive incuba­
tions with mouse IgG covalently coupled to protein A-Sepharose CL-4B 
beads (Pharmacia Fine Chemicals, Piscataway, NJ). Precleared lysates were 
incubated for 3-4 h with a specific mAb coupled to protein A-Sepharose. 
The immunoprecipitates were removed from the lysates by centrifugation 
at 13,000 g, Subsequently, immunoprecipitates were washed extensively in 
0.01 M triethanolamine/150 mM NaCl buffer, pH 7.8, 1% NP-40, in the pres­
ence or absence of 1 mM CaCh and/or 1 mM MgCh.
Electrophoresis and Autoradiography
SDS-PAGE was carried out on vertical slab gels (5-15 %) according to a 
modification of the Laemmli procedure (Laemmli, 1970). Samples were 
analyzed under reducing conditions, with 5% 2-mercaptoethanol in SDS 
sample buffer. Kodak XAR-film was used in combination with intensifier 
screens (Cronex Lightning Plus; Dupont Chemical Co., Newtown, CT) for 
autoradiography of ,25I-Iabeled materials.
Analysis of Cytosolic Free Calcium ([Ca2+]i)
Cells loaded with the fluorescent calcium-sensitive dye indo-1, were used 
to analyze changes in [Ca2+]i. 107 cells/ml were incubated in medium con­
taining 1 mM indo-l/AM (Molecular Probes) for 15 min, followed by 
fivefold dilution with fresh medium and incubation for another 30 min. Sub­
sequently, cells were washed and [Ca2+]i changes were measured upon the 
addition of mAb, in a spectrofluorimeter (X excitation — 340 nm and X 
emission = 390 nm) after 15 min preincubation at 37°C. Calibration of the 
fluorescence signal in terms of [Ca2+]i was carried out according to Bij- 
sterbosch et al. (1986).
Results
Expression of the NKI-LL6 Epitope of LFA-1 on Resting 
Versus Activated Lymphocytes
In a previous report (Keizer et al., 1988) we have described 
a mAb, NKI-L16, that reacts with the a chain of LFA-1, and 
induces LFA-1-dependent cell aggregation. Here we show 
that the epitope recognized by NKI-L16 is differently ex­
pressed on resting and activated cells. A homogeneous popu­
lation of resting lymphocytes, isolated from peripheral 
blood, shows low expression of the NKI-L16 epitope as com­
pared to other LFA-1 epitopes as detected by SPV-L7 and 
NKI-L15 mAbs (Table I) (Keizer et al., 1988; Larson et al., 
1990). Culture of resting lymphocytes in Iscove’s medium 
containing 10% FCS for 24 h resulted in a significant (two­
fold) increase in expression of the NKI-L16 epitope. This 
was not accompanied by a concomitant increase in expres­
sion of other LFA-1 epitopes, since no enhanced binding of 
other anti-LFA-1 a (Table I) or /3 (CLB LFA 1/1; not shown) 
antibodies was observed. An even greater increase (300%) 
in expression of the NKI-L16 epitope was found when rest­
ing lymphocytes were stimulated with 10 ng/ml PMA (24 h) 
or with 100 U/ml IL-2 (48 h) (Thble I). From these results 
we conclude that activation of resting cells by in vitro cul­
ture, as detected by increased expression of CD25 and acti­
vation inducer molecule (AIM), induces expression of the 
NKI-L16 epitope of LFA-1, whereas the number of LFA-1 
molecules expressed at the cell surface is not significantly al­
tered. Expression of ICAM-1, a counter-structure of LFA-1, 
remained equally expressed during culture, whereas culture 
in the presence of IL-2 leads to a small (50%) increase in 
expression. Cloned CD3+CD8+ or CD3+CD4+ CTL cells, 
or cloned CD3~ NK cells, show a twofold higher expres­
sion of LFA-1 and ICAM-1 as compared to resting or short 
term cultured lymphocytes (Table I). However, these cloned 
T cells express 10-fold higher levels of the NKI-L16 epitope 
compared to resting cells, compatible with the notion that 
NKI-L16 recognizes an activation epitope on the LFA-1 mol­
ecule.
Table I  Effect of Activation of Lymphocytes on the NKI-LÎ6 Expression
Cell type Culture period
Relative fluorescence intensity
NKI-L16/SPV-L7Control CD25 RR 1/1 SPV-L7 NKI-L15 NKI-L16
Lymphocytes*
d
Medium 0 4 18 (23)* 41 165 153 32 (19)* 0.19
1 4 61 (49) 45 178 150 69 (95) 0.38
3 3 100 (81) 53 197 172 73 0.37
PMA 1 4 148 75 195 174 85 0.44
IL-2 2 4 113 61 188 167 109 0.58
T cell clone JS-136§
Medium 5 6 75 81 303 280 248 0.81
* Lymphocytes were cultured for various days in Iscove’s medium containing 10% FCS, with or without PMA (10 ng/ml), or IL-2 (100 U/ml). 
i Percentage positive cells (if less than 100%).
& JS-136 T cells were used 5 d after the addition of allogeneic feeder cells, PHA and IL-2.
A typical experiment out of four is shown,
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Figure L Effect of the activation state of lymphocytes on the ki­
netics of aggregation. Aggregation was induced with optimal con­
centration PMA (10 ng/ml) and followed in time (scored under mi­
croscope). Aggregation of resting PBL, day 0 (•), PBL cultured 
for 1 (b) and 3 (o) d in Iscove’s medium containing 10% FCS, and 
JS-136 T cells (a) was compared. The spontaneous aggregation of 
PBL (a ) was always <10%. JS-136 cells were used after 5 d of cul­
ture in the presence of PHA, IL-2, and allogeneic feeder cells, 
when spontaneous aggregation was <20%. One representative ex­
periment out of four is shown (SD <10%).
LFA-l-mediated Adhesion Depends on Expression of 
the NKI-U6 Epitope
mAb NKI-L16 induces homotypic cell aggregation of differ­
ent lymphoid cells, such as T and B lymphocytes, NK cells 
(Keizer et al., 1988; Van Kooyk et al., 1989) and monocytes 
(data not shown), which can be completely bocked by anti- 
LFA-1 or anti-ICAM-1 mAbs, indicating that the induced 
aggregation primarily involves the LFA-l/ICAM-1 adhesion 
pathway. Depending on the activation state of the cells, 
aggregation is induced within 1-21 h of incubation (Fig. 1). 
Induction of adhesion by phorbol ester PMA (Fig. 1) or NKI- 
L16 antibodies (not shown) of freshly isolated resting periph­
eral blood lymphocytes is slow and takes 21 h of incubation 
to obtain 40% of the cells in aggregates. However, culture 
of these resting cells in Iscove’s medium containing 10% 
FCS for 1 or 3 d, leads to activation of the cells, allowing 
the lymphocytes to respond much faster to PMA or NKI-L16 
antibodies, and aggregate (30%) within 2 h after stimulation. 
Cells of a human allogeneic T cell clone (JS-136), cultured 
for 5 d in the presence of alloreactive stimulator cells, 
representing highly activated lymphocytes, as determined by 
high CD25 and AIM expression, are able to aggregate (40%) 
within 1 h after stimulation with PMA (Fig. 1), anti-CD3-, 
or NKI-L16 antibodies (not shown). These results show that 
NKI-L16 epitope expression clearly correlates with the ki­
netics of aggregation induced by PMA or other stimuli (data 
not shown). Low NKI-L16 expression, only found on rest­
ing lymphocytes, corresponds with a slow induction of 
homotypic cell aggregation, whereas preactivated cells with 
high NKI-L16 expression can be induced to aggregate almost 
immediately
These results suggest that the NKI-L16 epitope is an acti­
vation epitope and that expression of this epitope is as­
sociated with LFA-l-mediated adhesion. However, it should 
be noted that expression of this epitope in itself is not 
sufficient to induce aggregation, since CTL cannot aggregate 
spontaneously, despite high NKI-L16 expression (Fig. 1).
JS 136 
PBL 3 d 
PBL 1 d 
PBL Od 
Con trol
Clustering of integrin receptors has been shown to be 
strongly associated with adhesion promoting activity (Det- 
mers et al., 1987). To exclude the possibility that the NKI- 
LI6-induced aggregation is the result of crosslinking of 
LFA-1 molecules or of crosslinking of cells by binding to Fc 
receptors, Fab fragments of NKI-L16 were tested on their 
ability to induce cluster formation. Fab fragments were free 
of any contamination of intact IgG or F (ah') 2 fragments, as 
judged by SDS-PAGE after silverstaining, which allowed de­
tection of contaminating total IgG or F(ab' ) 2  at levels as low 
as 0.2% (Fig. 2, A and B). In addition, a sensitive ELISA 
was performed, (detection limit 0.01 ng/ml) in which the ab­
sence of intact Fc fragments was confirmed (data not shown). 
Addition of 1 /¿g/ml NKI-L16 Fab fragments to T-cell clone 
JS-136 induced cluster formation (Fig. 2 C). Aggregation in­
duced by Fab NKI-L16 was comparable to that induced by 
purified total IgG, although the Fab fragments were some­
what less effective, possibly due to a lower binding affinity. 
From these results we conclude that the cluster formation in­
duced by NKI-L16 is the result of specific binding to LFA-1, 
and is not caused by crosslinking of LFA-1 molecules or by 
binding to FcR.
4
Involvement of Cations in the Formation of the 
NKI-I16 Epitope
Since Ca2+ and Mg2+ ions are important for functional ac­
tivity of the LFA-1 molecule (Rothlein and Springer, 1986), 
we investigated the role of these cations in the formation of 
the NKI-L16 epitope. Immunoprécipitation studies revealed 
that mAb NKI-L16 weakly precipitated LFA-1 when chelating 
agents such as EDTA or EGTA were present in the lysis 
buffer, whereas other LFA-1 mAbs, such as NKI-L15, readily 
precipitated LFA-1 under these conditions (Fig. 3, B, C, F} 
and G). However, in the presence of Ca2+ and Mg2+ ions 
(Fig. 3, D  and E )y or in the presence of Ca2+ alone (Fig. 3, 
H  and /), similar quantities of LFA-1 were precipitated from 
peripheral blood mononuclear cells, with NKI-L16 com­
pared to NKI-L15. The fact that the presence of EGTA, 
which specifically removes Ca2+ cations, abrogates LFA-1 
precipitation by mAb NKI-L16, indicates that the presence 
of Ca2+ cations is essential for the expression of the NKI- 
L16 epitope. Although expression of NKI-L16 on resting 
lymphocytes is low in the presence of cations, NKI-L16 
could precipitate equal amounts of LFA-1 compared to
other anti-LFA-1 mAbs. It can not be excluded that solubili-
i
zation of the cell membrane alters the tertiary structure of 
LFA-1, causing exposure of the NKI-L16 epitope. This no­
tion is supported by the finding that isolation of the LFA-1 
molecule yields only the activated form of LFA-1 (Dustin and 
Springer, 1988).
Cation dependency of the expression of the NKI-L16 epi­
tope was further substantiated by immunofluorescence stud­
ies carried out with JS-136 T cells. The NKI-L16 epitope 
was completely lost upon incubation with EDTA or EGTA 
(Tàble II), whereas expression of other epitopes on LFA-1 
recognized by the mAbs SPV-L7 or NKI-L15 remained 
unaffected. Interestingly, addition of CaCl2 to the EDTA- 
treated cells completely restored expression of the NKI-L16 
epitope, whereas the addition of MgCl2 could not restore 
NKI-L16 expression. Addition of Ca2+ ions in combination 
with Mg2+ ions resulted in a restored NKI-L16 expression,
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Figure 2. SDS 10% PAGE un­
der nonreducing conditions of 
10 jig of NKI-L16 Fab (lane 
A) and 10 /xg of NKI-L16 
IgG2a (lanei?)- (C) Compar­
ison of purified NKI-L16 IgG 
and NKI-L16-Fab fragments 
in their capacity to induce ho- 
motypic aggregation of JS- 
136 T cells. The percentage of 
aggregation was measured 
qualitatively after 45 min in­
cubation at37°C. Protein con­
centrations ranged from 0.1 
ng/ml to 105 ng/ml total IgG 
(•), or Fab fragment (o). 
One experiment out of three is 
shown (SD <10%).
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although expression was somewhat lower compared to addi­
tion of only Ca2+ ions alone.
These results indicate that the expression of the unique 
epitope recognized by NKI-L16 depends on the presence of 
Ca2+ ions, which are required to create the NKI-L16 
epitope.
Are Signal Transduction Pathways Involved in the 
NKI~L16-induced Cell Aggregation?
In an attempt to find out how NKI-L16 induces LFA-l-medi- 
ated cell adhesion, we compared different stimuli that are 
able to induce homotypic cell aggregation. The protein ki­
nase C (PKC) activator PMA as well as the functionally im­
portant CD3 receptor, expressed on T lymphocytes, are able 
to induce homotypic cell aggregation (Patarroyo et al., 1985;
Table II. Effect o f Cations on NKI-LÎ 6 Epitope Expression
Figure 3. The effect of the presence of cations on the immunopré­
cipitation of LFA-1 from 125I-labeled lysate of peripheral blood 
mononuclear cells with two different anti-LFA-1 mAbs, NKI-L15 
(B, D, F , and H) and NKI-L16 (C, E , G, and I ). Immunoprécipita­
tion in the absence of Ca2+ and Mg2+ ions through addition of
5 mM EDTA (B and C) or in the presence of 2 mM CaCl2 and 2 
mM MgCh (D and E) and in the absence of Ca2+ ions through ad­
dition of 5 mM EGTA (F and G) or the presence of 2 mM CaCk 
(Hand I). Lane A shows normal mouse control antibody. Bars in­
dicate relative molecular mass (kD) as defined by prestained mark­
ers. A representative experiment out of three is shown.
Treatment
Relative fluorescence intensity
Control SPV-L7 NKI-L15 NKI-L16
PBS 5 51 71 67
EGTA 5 76 68 5
EDTA 5 75 55 6
+ Mg2+ 7 70 78 11
+ Ca2+ 5 79 59 85
4- Mg2+ -h Ca2+ 7 77 55 63
JS-136 T lymphocytes were pretreated with 0.9% NaCl containing 5 mM 
EDTA or 5 mM EGTA for 1 h at 37°C, to remove all bound cations. Subse­
quently, cells were washed twice with cation-depleted PBS (dPBS), followed 
by the addition of 1 mM MgCl2 and/or 1 mM CaCU to the EDTA-treated 
cells, and incubated for 30 min at 4°C. Expression of different epitopes of 
LFA-1 was determined by immunofluorescence. A typical experiment out of 
four is shown.
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Figure 4. Comparison of the 
capacity of mAb NKI-L16 
(a) 0.5 mg/ml (20% aggrega­
tion); PM A (b), 20 ng/ml 
(17.4%); and mAb T3b anti- 
CD3 (c), 5 jig/ml (14.7%) to 
induce aggregation of JS-136 
T cells, quantitatively deter­
mined by double fluores­
cence. The NKI-L16-induced 
aggregation was blocked with 
anti-LFA-1 mAb CLB-LFA- 
1/1 (d) (1.8%) or anti-ICAM- 
1 mAb RR1/1 (e) (1.3%). 
Control (f) stimulation with 
anti-CD71 (transferrin recep­
tor). The percentage of ag­
gregates of JS-136 T cells are 
the percentage of double 
fluorescent events, after 45 
min incubation at 37°C. A 
typical experiment out of four 
is shown (SD =4%).
Rothlein and Springer, 1986; Dustin and Springer, 1989; 
Van Kooyk et al., 1989). Stimulation of the CD3 molecule 
by mAbs causes activation of PKC (Imboden and Stobo, 
1985), suggesting that activation of PKC directly affects 
LFA-l-mediated adhesion. Homotypic cell aggregations in­
duced by NKI-L16, PM A, or anti-CD3 antibodies, were
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Figure 5. Measurement of [Ca2+]i in JS-136 T cells. Addition of 50 
/ig/ml NKI-L16 (4-1) to 3 X 106 Indo-l-loaded cells was unable to 
increase (Ca2+]i, whereas stimulation with anti-CD3 antibodies 
(\2) resulted in an immediate response. Saturation of Indo-1 with 
extracellular Ca2+ was obtained after addition of 0.1% (wt/vol) 
Triton-X (¿3), and baseline levels of fluorescence were achieved 
upon addition of MnS04 solution (4-4). Similar results were ob­
tained in two other experiments.
compared in a quantitative manner. Purified NKI-L16 mAb 
or PMA induce aggregation of JS-136 T cells (Fig. 4, a and 
b, respectively). Similarly, addition of anti-CD3 antibodies 
also leads to induction of aggregation of JS-136 cells (Fig. 
4 c), but not of CD3 negative NK-clone cells, demonstrating 
the specificity of the response (not shown). Isotype-matched 
control mAbs did not induce aggregation (Fig. 4 /). Cell 
aggregation induced by NKI-L16 and the two other stimuli 
(anti-CD3 and PMA, data not shown) was LFA-l dependent, 
since it was completely inhibited by anti-LFA-l antibodies 
(Fig. 4 d), or anti-ICAM-1 antibodies (Fig. 4 e). These 
results demonstrate that these three stimuli are equally capa­
ble of inducing cell aggregation.
We next explored the possibility that these stimuli em­
ploy a similar activation pathway. PMA activates PKC 
(Nishizuka, 1984), and has been shown to phosphorylate the 
0 chain of LFA-l (Hara and Fu, 1986; Chatila and Geha, 
1988; Chatila etal., 1989). Thus, phosphorylation catalysed 
by PKC might activate LFA-l. Alternatively, it has been 
reported that LFA-l itself may transduce signals into the in­
terior of the cell (Carrera et al., 1988; Van Noesel et al., 
1988). We therefore investigated whether binding of mAb 
NKI-L16 to LFA-l leads to signal transduction. The possible 
involvement of PIP2 hydrolysis resulting in the production 
of inositol 1,4,5-triphosphate (IP3) and diacylglycerol, the 
physiological activator of PKC (Isakov et al., 1987), was 
studied indirectly by measuring the intracellular free Ca2+ 
concentration in JS-136 T cells, which would change due to 
IP3 production (Isakov et al., 1987). Addition of 50 /¿g/ml 
NKI-L16 had no effect on the cytosolic free Ca2+ concentra­
tion (Fig. 5), whereas subsequent addition of anti-CD3 anti­
body (5 fig/ml), which enhances the intracellular free Ca2+
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Table III. Effect of Different Signal Transduction 
Blockers, Temperature, and Cations on the PMA, NKI-L16 
and Anti-CD3 Induced Homotypic Aggregation o f  
T Cell Clone JS-136
Treatment
Aggregation of T cell clone JS-136 (%)
Control PMA NKI-L16 Anti-CD3
— 10 70 80 60
Staurosporine 10 10 80 20
AMG 10 10 80 10
Sodium azide 1:10 10 40 80 10
1:1 10 10 60 10
4°C 0 0 0 0
37 °C + Medium 10 70 80 60
+ EDTA 0 0 0 0
4* EGTA 0 0 0 0
Cells were stimulated with PM A (10 ng/ml) NKI-L16 (10 jitg/ml), or anti-CD3 
antibodies (10 ¿¿g/ml) in the presence or absence of various inhibitors. All in­
hibitors were added in optimal concentrations (Staurosporine, 200 nM; AMG, 
60 ¿¡M), and remained present during the test, After 45 min at 37°C, aggregate 
formation was scored visually. For inhibition with sodium azide (0.2% wt/vol 
1;]) cells were preincubated for 1 h at 4°C followed by addition of PMA, NKI- 
L16, or anti-CD3 antibodies. To determine aggregation in the absence of NKI- 
L16 epitope expression, cells were preincubated for 30 min at 4°C with 5 mM 
EDTA or 5 mM EGTA, followed by the aggregtion assay also performed in 
the presence of 5 mM EDTA or 5 mM EGTA for 45 min at 37 °C. Experiments 
were carried out in triplicate (SD <10%); the mean out of four experiments 
is shown-
concentration in T cells (Truneh et al., 1985), led to a 
significant response.
The possibility that NKI-LI6 activates PKC via diacyl- 
glycerol, derived from other cellular lipids, was examined by 
means of different inhibitors (Table ni). Two potent PKC 
blockers, AMG (Van Blitterswijk et al., 1987) and stau­
rosporine (Tamaoki et al., 1986), completely abrogated 
PM A- and anti-CD3-induced aggregation but were unable to 
block NKI-L16~induced aggregation. Furthermore, cells in 
which PKC activity was down-regulated by incubation for 
72 h in the presence of PDBU, were unable to aggregate in 
response to PMA, but were still responsive to NKI-L16 mAb 
(not shown). These data indicate that NKI-L16 indeed does 
not induce aggregation by activation of PKC. Addition of 
azide, an inhibitor of mitochondrial ATP production, abol­
ished PMA- and anti-CD3-induced adhesion but not NKI- 
L16~induced adhesion (Table III), suggesting that cell adhe­
sion induced by NKI-L16 is exclusively an extracellular 
phenomenon. Only addition of EDTA, or EGTA, which 
completely removes NKI-L16 expression, or incubation of 
cells at 4°C inhibited NKI-L16-induced adhesion, showing 
that cations, temperature and NKI-L16 expression are both 
important for LFA-l-mediated adhesion. Moreover, the ex­
pression of the NKI-L16 epitope in itself is not sufficient to 
induce aggregation, since JS-136 T cells do not spontane­
ously aggregate, but require stimuli to induce aggregation.
To determine whether binding of NKI-LI 6 indirectly 
stimulates other cellular processes, through at presently un­
known signaling routes, we investigated induction of early 
activation markers by direct fluorescence studies. We mea­
sured expression of die AIM and IL-2R (CD25) that appear 
early (20 h) on membranes of T cells upon stimulation with 
PMA or after triggering of TCR/CD3 (Cebrian et aL, 1988). 
Culture of resting lymphocytes for 24 h in the presence of
Table IV. Expression ofIL-2R and AIM on Lymphocytes 
Cultured in the Presence of NKI-LI 6
Lymphocytes cultured in
Relative fluorescence intensity
Control CD25 AIM
Medium 4 (2)* 45 (43)* 4 (2)*
NKI-L16 3 (2) 30 (24) 4 (2 )
IL-2 4 (2) 85 (100) 4 (2)
PMA 4(2) 49 (73) 127 (100)
NKI'L 15 4 (2) 36 (27) 4 (2 )
* Percentage positive cells.
Lymphocytes were cultured for 24 h in Iscove’s medium containing 10% 
FCS, in the presence of different activation stimuli (100 U/ml rIL-2 or 10 
ng/ml PMA). Antibodies NKI-L16 (10 jig/ml) or NKI-L15 (10 /xg/ml) were 
added to lymphocytes and cultured for 24 h. IL-2R and AIM expression were 
determined by direct immunofluorescence. A representative experiment out of 
three is shown.
mAb NKI-LI 6 neither increased AIM nor IL-2R expression 
above background levels induced by culturing in Iscove’s 
containing 10% FCS. Culturing of resting lymphocytes with 
10 ng/ml PMA, however, resulted in increased expression of 
AIM as well as IL-2R (Tkble IV). These results indicate that 
mAb NKI-L16 solely activates the LFA-l molecule and does 
not cause cell activation.
mAb NKI-L16 Induces Adhesion of JS-136 T Cells to I  CAM-1
To demonstrate that the induced cell adhesion by NKI-L16 
antibodies involves the LFA-l/ICAM-1 interaction, and to 
prove that LFA-l activation is involved rather than ICAM-1 
activation, we performed adhesion experiments with JS-136 
T cells to purified ICAM-1. The finding that mAb NKI-L16 
recognizes LFA-l-transfected COS cells (data not shown; 
Larson et al., 1990) indicates that NKI-L16 recognizes 
specifically LFA-l and not possible LFA-l-associated mole­
cules. JS-136 cells are highly activated cells that bind 
aspecific to BSA for 4% of total cells, but show an increased 
specific binding to ICAM-1 of 29 % (Fig. 6). Incubation of 
JS-136 T cells with mAb NKI-L16 or Fab fragments thereof 
for 30 min at 4°C, leads to an enhanced adhesion to ICAM-1 
up to 73 and 57 %, respectively. Anti-LFA-1 antibodies could 
block the adhesion to ICAM-1 completely (data not shown). 
The finding that the Fab fragments are slightly less effective
JS136 -t-NKI-Lló Fab
JS136 + N1C1-L16 IgG
0  control BSA 
■ ICAM-1
JS136
—i----- - ---- r
40 60
% cells bound
Figure 6. Binding of JS-136 T cells to purified ICAM-1 after 30 
min incubation at 37°C. 5!Cr-labeled JS-136 T cells were in­
cubated in microtiter wells coated with BSA (0) or with purified 
ICAM-1 (■). Separate parts of the cells were incubated for 30 
min at 4°C with 50 ¿ig/ml mAb NKI-L16 IgG, or 50 /¿g/ml NKI- 
L16 Fab, before the adhesion assay.
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in enhancing binding to purified ICAM-1 is in line with the 
findings of the aggregation assay where the Fab fragments 
also show lower binding affinity. These data indicate that 
mAb NKI-L16 or Fab fragments, can specifically activate the 
LFA-1 molecule thus increasing ligand binding. Further­
more, the increased adhesion through activation of LFA-1, 
induced by NKI-L16, excludes the involvement of conforma­
tional changes of its ligand ICAM-1 or involvement of in­
creased expression of ICAM-1,
Taken together, these experiments indicate that cell aggre­
gation induced by NKI-L16 antibodies is an exclusively ex­
tracellular event leading to an increased binding to ICAM-1, 
which is not due to crosslinking phenomena or to demon­
strable induction of signaling pathways that stimulate other 
cellular processes. We therefore hypothesize that binding of 
NKI-L16 to the extracellular portion of the LFA-1 molecule 
leads to a conformational change in LFA-1, resulting in a 
high-affinity state of the LFA-1 molecule.
Discussion
In this study we show that the LFA-1 a chain antibody NKI- 
L16 defines a Ca2+-dependent activation epitope. The epi­
tope is essentially absent from resting lymphocytes (Table I) 
and monocytes (our unpublished results), but becomes ex­
pressed upon in vitro culture, whereas expression of other 
LFA-1 epitopes remains unchanged. This suggests that lym­
phocytes must reach a certain activation stage to express this 
epitope. At present it is not known whether the increased epi­
tope expression upon cell activation is the result of more 
binding sites that become available or of a greater affinity of 
the NKI-L16 mAb for the epitope (under investigation), 
LFA-1“ t ran fee ted COS cells express the NKI-L16 epitope 
(Larson et al., 1990), demonstrating that the epitope is ex­
pressed by LFA-1. However we can not rule out the possibil­
ity that other molecules interacting with LFA-1 affect NKI- 
L16 expression, when resting lymphocytes are cultured in 
vitro.
We observed that the expression of the NKX-L16 epitope 
correlates with the capacity of lymphocytes to aggregate af­
ter triggering w ith PM A , anti-CD3 antibodies, or NKI-L16, 
The enhanced capacity of the cells to aggregate could not be 
attributed to increased LFA-1 expression, which did not alter 
significantly (Thble I). In addition, induction of expression 
of ICAM-1 after culture with IL-2 (T&ble I and Dustin and 
Springer, 1988) is low (50%) compared to the increased 
NKI-L16 epitope expression (300%). The NKI-L16 epitope 
thus may distinguish resting lymphocytes from (recently) ac­
tivated lymphocytes* However, it must be emphasized that 
expression of the NKI-L16 epitope, although essential, is not 
sufficient to induce cell adhesion. This is best illustrated by 
T cell clones (CD4* or CD8+), or NK cell clones (CD3~), 
that express constitutively high levels of this epitope, but do 
not spontaneously aggregate, unless specifically stimulated 
(by antigen, anti-CD3 antibodies, PMA, or by extracellular 
binding of NKI-L16 antibodies).
Therefore, we propose that LFA-1 can be expressed on the 
cell membrane in three distinct forms (Figdor et al., 1990). 
The first is an inactive form of LFA-1 in which the NKI-L16 
epitope is absent or only partially exposed. This form is pri­
marily expressed by resting lymphocytes. The second is an 
intermediate form that expresses the Ca2+-dependent NKI-
L16 epitope. This intermediate form is expressed by activated 
PBL and mature lymphocytes, and can be rapidly converted 
by specific triggering of the TCR/CD3 complex, PMA, or 
by binding of NKI-L16 antibodies, into the third form, acti­
vated LFA-1, which is possibly created by a conformational 
change of LFA-1. It should be noted that transition of the sec­
ond (intermediate) form to the third (active) form is not as~ 
sociated with a further increase in expression of the NKI-L16 
epitope.
LFA-l-mediated cell adhesion requires the presence of 
Mgz+ and at suboptimal Mg2+ concentration also Ca2+ ions 
(Rothlein and Springer, 1986; Marlin and Springer, 1987). 
They are thought to stabilize the interaction between the a 
and j3 subunits of LFA-1 (Corbi et al,, 1987) and the LFA- 
1-ligand complex (Larson et aL, 1988). We found that ex­
pression of the NKI-L16 epitope is absolutely dependent on 
the presence of Ca2+ cations; binding of Ca2+ presumably 
alters the tertiary structure of LFA-1. Possibly, expression of 
the NKI-L16 epitope is in some way associated with the for­
mation of clusters of LFA-1 (Figdor et al,, 1990) stabilized 
by Ca2* ions. Preliminary experiments indicate that LFA-1 
is clustered on CTL expressing high levels of NKI-L16 com­
pared to dispersed distribution on resting lymphocytes. The 
fact that NKI-L16 epitope expression is low on resting lym­
phocytes, in spite of Ca2+ presence in serum, indicates that 
Ca2+ binding to LFA-1 is an active process. It is tempting to 
speculate that the NKI-L16 antibody binds to a site on the 
LFA-1 molecule that is in close proximity to the cation- 
binding region.
Recently, Dransfield and Hogg (1989) defined an antibody 
(mAb 24) that recognizes a strictly Mg2+-dependent epitope
on all three leukocyte integrin a subunits, possibly as­
sociated with functionally active molecules. Expression of 
this epitope is temperature and energy dependent and in­
hibits adhesion-dependent processes. In contrast, mAb NKI- 
L16 induces LFA-l-dependent adhesion and recognizes an 
activation epitope restricted to the a chain of LFA-1, which 
is Ca2* dependent and temperature independent. Both ob­
servations suggest that binding of different cations may alter 
the conformation of LFA-1, and thereby the functional status 
of the receptor. The importance of cation-binding domains 
on the functional state of the integrins is also demonstrated 
by a recently described mAb that reacts with a Ca2+- 
binding site of GPIIb and induces platelet aggregation (Gu- 
lino et al., 1990). Platelet activation is associated with 
changes in the GPIIb/IIIa complex, most likely by a confor­
mational change.
Indirect evidence suggests that LFA-1 is capable of trans­
mitting signals into the interior of the cell, since anti-LFA-1 
antibodies have been demonstrated to enhance anti-CD3-in­
duced cell proliferation (Carrera et al., 1988; Van Noesel et 
al., 1988). However, based on recent observations (Dustin 
and Springer, 1989; Van Kooyk et al., 1989) it cannot be ex­
cluded that enhanced proliferation is the result of enhanced 
cell-cell interactions by activation of LFA-1 through CD3, 
Cell aggregation induced by NKI-L16, however, is not likely 
to be mediated by signals generated through LFA-1, because 
blocking of signal transduction pathways does not affect in­
duction of cell aggregation by NKI-L16, whereas it com­
pletely abrogates PMA-induced cell aggregation. Further 
evidence shows that PKC down-regulation, by prolonged in­
cubation of cells with PDBU, does not influence the NKI-
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L16~induced aggregation (not shown). Furthermore, induc­
tion of aggregation by NKI-L16 was not accompanied by a 
concomitant induction of early activation markers, such as 
IL-2R and AIM, which are readily induced by PM A, sug­
gesting that NKI-L16 does not lead to cell activation through 
unknown signaling routes. Finally, the observation that Fab 
fragments of NKI-L16 are also capable of inducing cell ag­
gregation excludes the involvement of crosslinking phenom­
ena. We therefore hypothesize that binding of the antibody 
causes a conformational change of the LFA-1 molecule, con­
verting it from an inactive (second form) into an active state 
(third form). This would allow binding of its ligands with 
high affinity, resulting in stable cell adhesion. Although NKI- 
L16 and PMA act quite differently on LFA-1, the kinetics of 
the aggregation response to both stimuli are remarkably sim­
ilar (Keizer et al., 1988). We therefore assume that stimula­
tion with PMA might, via PKC (Nishizuka, 1984), lead to 
a similar intramolecular change of LFA-1.
Activation of LFA-1 is a dynamic process. Recent observa­
tions showed that activation of LFA-1 can be differentially 
regulated. Anti-CD3 antibodies induce LFA-l-dependent 
aggregation by transient activation of the LFA-1 molecule 
(Dusting and Springer, 1989; Van Kooyk et al., 1989), 
whereas anti-CD2 antibodies persistently activate LFA-1 
(Van Kooyk et al., 1989). Activation of LFA4 via CD2 or 
CD3 probably occurs by the generation of second mes­
sengers leading to PKC activation (Imboden and Stobo, 
1985; Pantaleo et al., 1987). Whether triggering of CD43, 
which has also been shown to induce LFA-l-dependent adhe­
sion (Axelsson et al., 1988), results in activation of PKC re­
mains to be determined.
Activation of PKC by PMA may lead to phosphorylation 
of the LFA-1 j8 subunit (Hara and Fu, 1986; Chatila and 
Geha, 1988; Chatila et al., 1989). We speculate that PKC- 
dependent phosphorylation processes induce intramolecular 
changes in LFA-1 and thus control activation of LFA-1 (Fig- 
dor et al., 1990). Alternatively, activation of PKC can lead 
to the phosphorylation of cytoskeletal components, which 
then might interact with LFA-1 thus leading to enhanced cell 
adhesion.
We provided evidence that LFA-l-mediated lymphocyte 
adhesion is regulated by PKC-dependent mechanisms, when 
triggered by anti-CD3 mAb or PMA, presumably giving 
rise to a conformational change of the LFA-1 molecule. 
Ca2f/Mg2+ cations play a central role in this process. Re­
cently similar mechanisms are employed by other members 
of the integrin family (Gulino et al., 1990). Both GPIIb/IIIa 
and CR3 (CDllb/CD18) have been shown to express neo­
epitopes upon activation, indicating that activation causes in­
tramolecular modifications which may alter ligand affinity 
(Wright and Meyer, 1986; Ding et al., 1987; Altieri and Edg- 
ington, 1988; Philips et al., 1988; Danilov and Juliano, 
1989).
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